JPRN-UMIN000029909已完成未知
Evaluation of effects of the use of commercial xylitol gum on improvement in oral environment - Effects of xylitol gum on improvement in oral environment
Kyushu University Faculty of Dental Science0 个研究点目标入组 100 人开始时间: 2017年11月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 60years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1) Edentulous subjects 2) Subjects using antibacterial drug 3) Subjects using xylitol chewing gum routinely
研究者
相似试验
进行中（未招募）
1 期
A Study to Evaluate the Efficacy and Safety of XyloCore, a Glucose Sparing Experimental Solution, for Peritoneal Dialysis (ELIXIR)End-Stage Kidney DiseaseMedDRA version: 21.1Level: LLTClassification code: 10014646Term: End stage renal disease (ESRD) Class: 10038359CTIS2024-513562-19-00Iperboreal Pharma S.r.l.170
进行中（未招募）
1 期
A Study to Evaluate the EffIcacy and Safety of XyloCore, a low-glucose solution for peritoneal dialysisEnd-Stage Renal Disease (ESRD)MedDRA version: 21.0Level: PTClassification code 10077512Term: End stage renal diseaseSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2019-004183-21-DEIperboreal Pharma Srl170
进行中（未招募）
1 期
A Study to Evaluate the EffIcacy and Safety of XyloCore, a low-glucose solution for peritoneal dialysisEnd-Stage Renal Disease (ESRD)MedDRA version: 21.0Level: PTClassification code 10077512Term: End stage renal diseaseSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2019-004183-21-DKIperboreal Pharma Srl170
招募中
1 期
Study to evaluate the effIcacy and safety of a solution for peritoneal dialysis with a low glucose contentEUCTR2019-004183-21-ITIPERBOREAL PHARMA S.R.L.170
进行中（未招募）
不适用
Safety and efficacy of a new solution, XyloCore, for peritoneal dialysisChronic kidney diseaseISRCTN16169961Sintesi Research170